Sanofi-Aventis Menactra Market Is $3.5 Bil. Over 10 Years, CDC Says
The potential market for Sanofi-Aventis' meningococcal conjugate vaccine Menactra is $3.5 bil. over 10 years, a Centers for Disease Control & Prevention analysis indicates
The potential market for Sanofi-Aventis' meningococcal conjugate vaccine Menactra is $3.5 bil. over 10 years, a Centers for Disease Control & Prevention analysis indicates